- Medicine Advertisements Board (MAB) Guidelines And Policy
- Application To Import/Manufacture Unregistered Products For The Treatment of Life-Threatening Illnesses (Private/Non-MOH Institutions)
- Qualifying Examination to Practice Pharmacy
- Medicine Advertisements Board
- List of Training Premises for Provisionally Registered Pharmacist (PRP)
You are here
Search
Dipaparkan jumlah carian 211 - 220 daripada 1533
Kategori: Dokumen | Tarikh: 15 Oct 2023
Kategori: Dokumen | Tarikh: 15 Oct 2023
Kategori: Dokumen | Tarikh: 15 Oct 2023
Soalan-Soalan Lazim ini adalah selaras dengan penguatkuasaan Akta Racun (Pindaan) 2022 dan bertujuan sebagai rujukan kepada ahli farmasi berlesen dan ahli farmasi berdaftar.
Klik di sini...
Kategori: Soalan Lazim | Tarikh: 18 Oct 2023
These FAQs are in line with the enforcement of the Poisons (Amendment) Act 2022 and act as a reference for all licensed pharmacists and registered pharmacists.
If you have any enquiries, please...
Kategori: Soalan Lazim | Tarikh: 18 Oct 2023
Kategori: Berita | Tarikh: 15 Oct 2023
The increasing use of biological medicines including biosimilars in the Ministry of Health (MOH), Malaysia facilities warrants a suitable guidance document to ensure safe and appropriate...
Kategori: Dokumen | Tarikh: 15 Oct 2023
Susulan peningkatan dalam penggunaan ubat-ubatan biologik termasuk ubat biosimilar di fasiliti Kementerian Kesihatan Malaysia (KKM), satu garis panduan adalah diperlukan bagi menjamin amalan...
Kategori: Dokumen | Tarikh: 15 Oct 2023
[[{"type":"media","fid":"7817","view_mode":"media_original","instance_fields":"override","attributes":{"height":563,"width":1000},"field_file_image_alt_text[und][0][value]":"","...
Kategori: Artikel | Tarikh: 13 May 2024
During the annual #MedSafetyWeek global campaign, National Pharmaceutical Regulatory Agency (NPRA) collaborates with the Uppsala Monitoring Centre (UMC, the World Health Organisation (WHO)...
Kategori: Agenda | Tarikh: 15 Oct 2023